| abstract |
The present invention generally relates to antibodies that bind to GPRC5D, including bispecific antigen binding molecules e.g. for activating In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease. |